Showing results (401-410 of 630) with videos related to
Sort By:
Pageof 63
Scandinavian Journal of Immunology|September 30, 2008
CD8+CD60+ T cells, cells expressing epsilon specific mRNA and Th1/Th2 cytokines in cord blood and at 7 months of ageT A Smith-Norowitz, K B Norowitz, J I Silverberg, et al.The British Journal of Dermatology|January 17, 2018
Systematic review of atopic dermatitis disease definition in studies using routinely collected health dataM P Dizon, A M Yu, R K Singh, et al.American Journal of Clinical Dermatology|July 20, 2022
Tralokinumab Plus Topical Corticosteroids as Needed Provides Progressive and Sustained Efficacy in Adults with Moderate-to-Severe Atopic Dermatitis Over a 32-Week Period: An ECZTRA 3 Post Hoc AnalysisJonathan I Silverberg, David N Adam, Matthew Zirwas, et al.Journal of the American Academy of Dermatology|December 9, 2019
Measurement properties of the Patient-Reported Outcomes Measurement Information System Itch Questionnaire item banks in adults with atopic dermatitisJonathan I Silverberg, Jin-Shei Lai, Paras P Vakharia, et al.Journal of the American Academy of Dermatology|March 1, 2020
Prevalence of asthma in patients with atopic dermatitis: A systematic review and meta-analysisNanna Ravnborg, Danni Ambikaibalan, Gaurav Agnihotri, et al.The Pediatric Infectious Disease Journal|January 26, 2013
Asthmatic children have increased specific anti-Mycoplasma pneumoniae IgM but not IgG or IgE-values independent of history of respiratory tract infectionTamar A Smith-Norowitz, Jonathan I Silverberg, Melanie Kusonruksa, et al.The Journal of Allergy and Clinical Immunology. in Practice|March 13, 2025
Long-Term Safety of Abrocitinib in Moderate-to-Severe Atopic Dermatitis: Integrated Analysis by AgeMichael J Cork, Mette Deleuran, Bob Geng, et al.Journal of the European Academy of Dermatology and Venereology : JEADV|May 16, 2024
Optimizing maintenance therapy in responders to abrocitinib induction: A post hoc analysis of JADE REGIMENJ P Thyssen, J I Silverberg, J Ruano, et al.Dermatology and Therapy|September 1, 2023
Comparative Efficacy of Targeted Systemic Therapies for Moderate-to-Severe Atopic Dermatitis without Topical Corticosteroids: An Updated Network Meta-analysisJonathan I Silverberg, H Chih-Ho Hong, Brian M Calimlim, et al.The Journal of Dermatological Treatment|October 27, 2024
Biologics and oral systemic treatment preferences in patients and physicians for moderate-to-severe atopic dermatitis: a discrete choice experiment in the United Kingdom and GermanyNicholas Durno, Pablo Arija, Krystallia Pantiri, et al.Pageof 63